Vasodilators, Htn, Angina, Hf, Antiarrhythmics

Front 1

Nitroglycerin class

Back 1

vasodilator, organic nitrate, veins

Front 2

Nitroglycerin TU

Back 2

acute therapy or angina, sustained therapy of angina, IV therapy for perioperative control of BP, controlled hypotension during surgery, HF, MI, and unstable angina

Front 3

Nitroglycerin AE

Back 3

headache, orthostatic hypotension, reflex tachycardia

Front 4

Nitroglycerin nursing implications

Back 4

Before administering assess BP, determine frequency, intensity, and location of angina pain. Discontinue slowly to prevent vasospasm. Allow 8 hours of drug-free time.

Front 5

Hydralazine class

Back 5

direct acting vasodilator, arterioles

Front 6

Hydralazine TU

Back 6

HTN, hypertensive crisis, HF

Front 7

Hydralazine AE

Back 7

reflex tachycardia, increased blood volume, systemic lupus erythematosus- like syndrome, headache, dizziness, weakness, fatigue

Front 8

Hydralazine nursing implications

Back 8

Monitor BP and HR and watch for adverse effects

Front 9

Sodium Nitroprusside class

Back 9

vasodilator, veins and arterioles

Front 10

Sodium Nitroprusside TU

Back 10

hypertensive emergencies, control bleeding in surgery by decreasing BP

Front 11

Sodium Nitroprusside AE

Back 11

excessive hypotension, cyanide poisoning, thiocyanate toxicity - if cyanide poisoning, stop drug and administer thiosulfate

Front 12

Sodium Nitroprusside nursing implications

Back 12

Monitor BP, for sodium and water retention and for signs of cyanide and thiocyanate toxicity

Front 13

Clonidine

Back 13

centrally acting Alpha 2 receptor agonist

Front 14

Propanolol, Metoprolol, Atenolol

Back 14

Beta 1 receptor antagonist

Front 15

Prozasin

Back 15

Alpha 1 receptor antagonist

Front 16

Hydralazine, Sodium Nitroprusside

Back 16

act on vascular smooth muscle

Front 17

Hydrochlorothiazide, Furosemine, Spironolactone

Back 17

Diuretics

Front 18

Enalapril

Back 18

ACE inhibitor

Front 19

Losartan

Back 19

angiotensin II receptors, ARBs

Front 20

Eplerenone, Spironolactone

Back 20

aldosterone receptors

Front 21

Aliskiren

Back 21

inhibits renin

Front 22

Verapamil, Diltiazem, Amlodipine, Nifedipine

Back 22

calcium channel blockers

Front 23

Digoxin class

Back 23

positive inotrope, cardiac glycoside

Front 24

Digoxin TU

Back 24

HF, cardiac dysrhythmias

Front 25

Digoxin AE

Back 25

cardiac dysrhythmias (AV block, bradycardia, ventricular flutter and fibrillation), GI (anorexia, nausea, vomiting), fatigue, visual disturbances (yellow tinge, halos around objects, blurred vision)

Front 26

Digoxin nursing implications

Back 26

monitor HR, EKG, potassium, kidney fx, digoxin plasma level

Front 27

Carvedilol, Sustained release Metoprolol

Back 27

Beta blocker used in HF management

Front 28

Procainamide class

Back 28

Class IA antidysrhythmic, sodium channel blocker, delays depolarization, Slowrate of impulse conduction in atria, ventricles and His-Purkinje system

Front 29

Procainamide TU

Back 29

atrial and ventricular dysrhythmias, can be used acutely for ventricular tachycardia and fibrillation

Front 30

Procainamide AE

Back 30

systemic lupus erythematosus-like syndrome, blood dyscrasias, cardiotoxicity, GI symptoms, hypotension, arterial ambolism

Front 31

Procainamide nursing implications

Back 31

Monitor EKG, pulse, CBC, renal function, plasma drug levels

Front 32

Lidocaine class

Back 32

Class IB antidysrhythmic, sodium channel blocker, accelerates repolarization, Reducecalcium entry and depress phase 4 depolarization; reduce automaticity, slowconduction velocity, and reduce contractility

Front 33

Lidocaine TU

Back 33

only for ventricular dysrythmias

Front 34

Lidocaine AE

Back 34

CNS effects including drowsiness, confusion, paresthesis, convulsions and respiratory arrest

Front 35

Lidocaine nursing implications

Back 35

monitor EKG, plasma drug level

Front 36

Amiodarone class

Back 36

Class III antidysrhytmic, potassium channel blocker, Delayrepolarization; prolong action potential duration and refractory period

Front 37

Amiodarone TU

Back 37

approved for two ventricular dysrhythmias (recurrent ventricular fibrillation and hemodynamically unstable ventricular tachycardia)

Front 38

Amiodarone AE

Back 38

pulmonary toxicity, sinus bradycardia, AV block, HF, corneal microdeposits, blue-gray color to skin, GI, CNS reactions, hepatotoxicity, thyroid dysfunction

Front 39

Amiodarone nursing implications

Back 39

Monitor for adverse effects, EKG, pulse, signs of decreased cardiac output, pulmonary function tests, liver function tests, vision test, thyroid function tests